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Introduction {#jgs15675-sec-0005}
============

The emergence of antimicrobial resistance presents a serious public health threat and is propagated by inappropriate and extensive use of antimicrobials in all healthcare sectors. Residents in long‐term care facilities (LTCFs) are at risk of infections, and are challenging to assess, which prompts the overuse of antibiotics in this setting. Antibiotic use is extensive, and antibiotic resistance is common, in LTCFs.[1](#jgs15675-bib-0001){ref-type="ref"} The prevalence of residents receiving at least one antibiotic in a single year has been reported to be between 47% and 79%.[1](#jgs15675-bib-0001){ref-type="ref"}, [2](#jgs15675-bib-0002){ref-type="ref"} Furthermore, as in the acute‐care and primary care settings, residents in LTCFs are also vulnerable to inappropriate use, with estimated prevalence as high as 75%.[3](#jgs15675-bib-0003){ref-type="ref"}, [4](#jgs15675-bib-0004){ref-type="ref"} There is significant variability in antimicrobial use among various LTCFs and LTC prescribers.[2](#jgs15675-bib-0002){ref-type="ref"} Residents in facilities with higher antimicrobial use are more likely to experience negative outcomes, such as acquiring an antibiotic‐resistant organism.[5](#jgs15675-bib-0005){ref-type="ref"} A point‐prevalence study showed that up to 43% of long‐term care residents had positive culture results for at least one antimicrobial‐resistant pathogen.[6](#jgs15675-bib-0006){ref-type="ref"}

Guidelines for infection prevention and control in LTCFs encourage the program to include an antimicrobial stewardship component.[7](#jgs15675-bib-0007){ref-type="ref"} In addition, the US Centers for Medicare and Medicaid Services has mandated the implementation of antimicrobial stewardship programs (ASPs) in LTCFs since 2017.[8](#jgs15675-bib-0008){ref-type="ref"} Until recently, ASPs have existed mostly in the hospital setting, but they remain less well studied in LTCFs. Although the two different settings share the same antimicrobial stewardship goals, the structure and process differ considerably. LTCFs pose a unique challenge, with multiple factors that affect the quality of antibiotic prescribing decisions. For example, clinicians often have competing priorities and multiple roles, with many decisions being made off site.[9](#jgs15675-bib-0009){ref-type="ref"} Hospitals have invested considerably in developing ASPs, whereas most LTCFs lack the resources to emulate the ASP frameworks that have succeeded in acute‐care hospitals.

There has not been consensus on specific strategies or resources required to support ASP in LTC settings.[10](#jgs15675-bib-0010){ref-type="ref"} Implementation requires flexibility to target local needs and can be hindered by the limited resources and evidence available reflecting the effectiveness of ASP overall or the effectiveness of specific ASP strategies.[10](#jgs15675-bib-0010){ref-type="ref"} This systematic review aimed to provide a comprehensive summary of the characteristics of antimicrobial stewardship interventions in LTC and to use meta‐analysis to evaluate the impact of ASPs on overall antimicrobial use in LTCFs.

Methods {#jgs15675-sec-0006}
=======

Search Strategy {#jgs15675-sec-0007}
---------------

We conducted literature searches of three databases (CINAHL, Embase, and Ovid MEDLINE) for English‐language articles published between 1990 and July 31, 2018, which examined any antimicrobial stewardship intervention in an LTC setting. The broad search was conducted to ensure all primary research articles were captured and involved no limits by study design, intervention type, or outcome examined. The reference lists of relevant review articles were reviewed to identify studies that may have been missed in the electronic search.

Study Selection and Inclusion and Exclusion Criteria {#jgs15675-sec-0008}
----------------------------------------------------

Titles, abstracts, and full‐text screening were performed in duplicate by two independent reviewers. Any disagreement was resolved by discussion and consensus. There was no restriction on study design or patient population (eg, age and condition). Any type of LTCF was included (eg, long‐term care homes and nursing facilities). Studies involving interventions in an LTC ward within an acute‐care hospital were excluded because this group may not be generalizable to the broader LTCF population. There was no restriction according to the type of intervention or outcome, as long as the study objective was focused on implementation of an antimicrobial stewardship strategy with any outcome(s) reported after the intervention.

Data Extraction {#jgs15675-sec-0009}
---------------

Data extraction for predefined variables was undertaken by one reviewer, with 20% verified by a second reviewer. All outcomes were extracted (ie, patient, prescribing, and use) to demonstrate the variety of outcome types reported. All outcomes were presented narratively, only outcome data on antimicrobial use were extracted further for meta‐analysis (described later), and outcomes were extracted at the furthest time point if there were multiple measures after intervention. Data used for meta‐analyses were extracted in duplicate by two independent reviewers. Any disagreements were resolved by consensus. Intervention components were categorized by the Cochrane Effective Practice and Organization of Care (EPOC) taxonomy on implementation strategies,[11](#jgs15675-bib-0011){ref-type="ref"} with the addition of financial incentives, which is no longer listed as an implementation strategy.

Quality Appraisal {#jgs15675-sec-0010}
-----------------

Quality appraisal was performed in duplicate by two independent reviewers using the quality assessment tool for quantitative studies developed by the Effective Public Health Practice Project (EPHPP), which is designed to be applicable to a variety of public health interventions.[12](#jgs15675-bib-0012){ref-type="ref"} This tool assesses a range of study designs,[13](#jgs15675-bib-0013){ref-type="ref"} allowing all included studies in this review to be assessed by the same tool.

Meta‐Analysis {#jgs15675-sec-0011}
-------------

To provide a best estimate of the impact of antimicrobial stewardship on LTCF antimicrobial use, we performed a meta‐analysis to pool the results of any study that examined an outcome of antimicrobial use, regardless of the nature of the antimicrobial stewardship intervention. If a study reported multiple outcomes related to antimicrobial use, we selected the outcome that best approximated total use (rather than class‐ or condition‐specific antibiotic use). These outcomes varied across the studies, ranging from days of antibiotic therapy, to defined daily doses, to number of prescriptions per 1000 resident days. Therefore, we used a ratio of means approach for analyzing continuous outcomes, such that the effects of interventions would be comparable across these different outcome metrics.[14](#jgs15675-bib-0014){ref-type="ref"}, [15](#jgs15675-bib-0015){ref-type="ref"} The ratio of means was calculated by dividing the mean antimicrobial use in the antimicrobial stewardship intervention group by the mean antimicrobial use in the nonintervention group, for studies without preintervention data. For controlled studies, in which pre‐post data were available for both the intervention and nonintervention groups, we determined the ratio of the mean antimicrobial use in the post period divided by the pre period for both the intervention and nonintervention groups, and then calculated a ratio of these ratios. For pre/post studies without a control group, the postintervention data were divided by the preintervention data. Variances of each ratio were calculated assuming identical *P* values as the published *P* values (or the calculated *P* values from the published 95% confidence intervals \[CIs\]) provided for the differences, or differences of differences for each included study. For studies reporting ranges for differences or difference of differences, SDs were estimated from published ranges, as described by Wan et al.[16](#jgs15675-bib-0016){ref-type="ref"} The studies were weighted by the inverse of the variance to calculate pooled outcomes.[14](#jgs15675-bib-0014){ref-type="ref"} A random‐effects model was used, which incorporates between‐study heterogeneity and gives wider and more conservative CIs when heterogeneity is present.[17](#jgs15675-bib-0017){ref-type="ref"} Between‐study heterogeneity was assessed using the I^2^ measure, the percentage of total variability across studies attributable to heterogeneity rather than chance; and statistical heterogeneity was considered low if I^2^ was 25% to 49%, moderate if I^2^ was 50% to 74%, and high if I^2^ was 75% or greater.[18](#jgs15675-bib-0018){ref-type="ref"}

We performed a stratified meta‐analysis according to study design to examine the pooled effect size of antimicrobial strategies separately among cluster randomized controlled trials (RCTs), controlled pre‐post studies, and uncontrolled pre‐post studies. Last, we performed a sensitivity analysis excluding two studies that measured antimicrobial outcomes that were limited to a subset of infectious syndromes.[19](#jgs15675-bib-0019){ref-type="ref"}, [20](#jgs15675-bib-0020){ref-type="ref"} To assess for publication bias, a funnel plot comparing the effect measure with study precision for each study was examined for evidence of asymmetry.

Results {#jgs15675-sec-0012}
=======

A total of 4667 unique citations were identified; 4666 from the database search strategy and 1 additional study by searching the reference list of the identified reviews. Altogether, 18 articles met the inclusion criteria (see flowchart in Figure [1](#jgs15675-fig-0001){ref-type="fig"}). The study designs included pre and post (n = 9),[21](#jgs15675-bib-0021){ref-type="ref"}, [22](#jgs15675-bib-0022){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [26](#jgs15675-bib-0026){ref-type="ref"}, [27](#jgs15675-bib-0027){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"} controlled pre and post (n = 4),[19](#jgs15675-bib-0019){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"} cluster RCTs (n = 4),[20](#jgs15675-bib-0020){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [35](#jgs15675-bib-0035){ref-type="ref"} and patient‐level RCT (n = 1).[36](#jgs15675-bib-0036){ref-type="ref"} More than half of the studies did not report or target a specific condition (n = 11)[20](#jgs15675-bib-0020){ref-type="ref"}, [21](#jgs15675-bib-0021){ref-type="ref"}, [22](#jgs15675-bib-0022){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [27](#jgs15675-bib-0027){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [35](#jgs15675-bib-0035){ref-type="ref"}; the number of study sites ranged from 1 to 46. Most studies were conducted in the United States (n = 12),[19](#jgs15675-bib-0019){ref-type="ref"}, [21](#jgs15675-bib-0021){ref-type="ref"}, [22](#jgs15675-bib-0022){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [26](#jgs15675-bib-0026){ref-type="ref"}, [27](#jgs15675-bib-0027){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} followed by one each in Australia,[29](#jgs15675-bib-0029){ref-type="ref"} Canada,[35](#jgs15675-bib-0035){ref-type="ref"} Canada joint with United States,[34](#jgs15675-bib-0034){ref-type="ref"} Netherlands,[31](#jgs15675-bib-0031){ref-type="ref"} Sweden,[20](#jgs15675-bib-0020){ref-type="ref"} and the United Kingdom.[33](#jgs15675-bib-0033){ref-type="ref"} The earliest publication year was 2001.[36](#jgs15675-bib-0036){ref-type="ref"} Tables [1](#jgs15675-tbl-0001){ref-type="table"} and [2](#jgs15675-tbl-0002){ref-type="table"} and Supplementary Tables [S1](#jgs15675-supitem-0001){ref-type="supplementary-material"} and [S2](#jgs15675-supitem-0001){ref-type="supplementary-material"} summarize the details of the included studies and intervention strategies.

![Literature search and screening results. ASP indicates antimicrobial stewardship program; LTCF, long‐term care facility.](JGS-67-392-g001){#jgs15675-fig-0001}

###### 

Study and intervention characteristics of included studies

  Study first author                                         Country                    Study design          No. of sites   Participant treatment condition
  ---------------------------------------------------------- -------------------------- --------------------- -------------- ---------------------------------
  Cooper,[28](#jgs15675-bib-0028){ref-type="ref"} 2017       United States              Pre/post              1              UTI
  Doernberg,[26](#jgs15675-bib-0026){ref-type="ref"} 2015    United States              Pre/post              3              UTI
  Fleet,[33](#jgs15675-bib-0033){ref-type="ref"} 2014        United Kingdom             RCT: cluster          30             Any
  Furuno,[21](#jgs15675-bib-0021){ref-type="ref"} 2014       United States              Pre/post              1              NR
  Gugkaeva,[27](#jgs15675-bib-0027){ref-type="ref"} 2012     United States              Pre/post              1              NR
  Jump,[22](#jgs15675-bib-0022){ref-type="ref"} 2012         United States              Pre/post              1              NR
  Linnebur,[30](#jgs15675-bib-0030){ref-type="ref"} 2011     United States              Controlled pre/post   16             NHAP
  Loeb,[34](#jgs15675-bib-0034){ref-type="ref"} 2005         Canada and United States   RCT: cluster          24             UTI
  McMaughan,[19](#jgs15675-bib-0019){ref-type="ref"} 2016    United States              Controlled pre/post   12             UTI
  Monette,[35](#jgs15675-bib-0035){ref-type="ref"} 2007      Canada                     RCT: cluster          8              Any
  Naughton,[36](#jgs15675-bib-0036){ref-type="ref"} 2001     United States              RCT                   10             NHAP
  Pettersson,[20](#jgs15675-bib-0020){ref-type="ref"} 2011   Sweden                     RCT: cluster          46             Any
  Rahme,[23](#jgs15675-bib-0023){ref-type="ref"} 2016        United States              Pre/post              1              Any
  Stuart,[29](#jgs15675-bib-0029){ref-type="ref"} 2015       Australia                  Pre/post              1              NR
  Sloane,[24](#jgs15675-bib-0024){ref-type="ref"} 2014       United States              Pre/post              4              Any
  van Buul,[31](#jgs15675-bib-0031){ref-type="ref"} 2015     Netherlands                Controlled pre/post   10             NR
  Zabarsky,[25](#jgs15675-bib-0025){ref-type="ref"} 2008     United States              Pre/post              1              UTI
  Zimmerman,[32](#jgs15675-bib-0032){ref-type="ref"} 2014    United States              Controlled pre/post   12             Any

Abbreviations: NHAP, nursing home--acquired pneumonia; NR, not reported; RCT, randomized controlled trial; UTI, urinary tract infection.

###### 

Outcomes reported by included studies

  Study first author                                         Clinical outcome                                                                                Antimicrobial prescribing outcome                                                    Use outcome
  ---------------------------------------------------------- ----------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ------------------------------
  Cooper,[28](#jgs15675-bib-0028){ref-type="ref"} 2017       UTI incidenceAppropriateness of UTI diagnosisProvider knowledge                                 NR                                                                                   Urinalysis testing frequency
  Doernberg,[26](#jgs15675-bib-0026){ref-type="ref"} 2015    Consequence of antibiotic on clinical culture--rates of resistance organism                     Antibiotic use trendAcceptance of recommendation                                     NR
  Fleet,[33](#jgs15675-bib-0033){ref-type="ref"} 2014        NR                                                                                              Antibiotic useAppropriateness of prescribing                                         NR
  Furuno,[21](#jgs15675-bib-0021){ref-type="ref"} 2014       NR                                                                                              Appropriateness of prescribing                                                       NR
  Gugkaeva,[27](#jgs15675-bib-0027){ref-type="ref"} 2012     NR                                                                                              Appropriateness of prescribingAcceptance of recommendation                           NR
  Jump,[22](#jgs15675-bib-0022){ref-type="ref"} 2012         Admission to hospitalTransfer to hospitalRate of positive *Clostridium difficile* test result   Antibiotic use                                                                       NR
  Linnebur,[30](#jgs15675-bib-0030){ref-type="ref"} 2011     Mortality                                                                                       Appropriateness of prescribingLength of therapy                                      NR
  Loeb,[34](#jgs15675-bib-0034){ref-type="ref"} 2005         Admission to hospitalMortality                                                                  Antimicrobial use                                                                    Rate of urine cultures sent
  McMaughan,[19](#jgs15675-bib-0019){ref-type="ref"} 2016    NR                                                                                              Prescription counts for asymptomatic bacteriuria                                     NR
  Monette,[35](#jgs15675-bib-0035){ref-type="ref"} 2007      NR                                                                                              Appropriateness of prescribing                                                       NR
  Naughton,[36](#jgs15675-bib-0036){ref-type="ref"} 2001     Hospitalization ratesMortality                                                                  Appropriateness of prescribing                                                       NR
  Pettersson,[20](#jgs15675-bib-0020){ref-type="ref"} 2011   Admission to hospitalNumber of UTIs per resident                                                Proportion of infections treated with an antibiotic                                  
  Rahme,[23](#jgs15675-bib-0023){ref-type="ref"} 2016        Infection rates                                                                                 Antibiotic use                                                                       NR
  Stuart,[29](#jgs15675-bib-0029){ref-type="ref"} 2015       Indications for EENTI, RTI, skin or wound infection, or UTI                                     Antibiotic use                                                                       
  Sloane,[24](#jgs15675-bib-0024){ref-type="ref"} 2014       NR                                                                                              Antibiotic prescribing ratesAppropriateness of prescribing                           NR
  van Buul,[31](#jgs15675-bib-0031){ref-type="ref"} 2015     NR                                                                                              Appropriateness of prescribingAntibiotic use                                         NR
  Zabarsky,[25](#jgs15675-bib-0025){ref-type="ref"} 2008     NR                                                                                              Rates of treatment for asymptomatic bacteriuriaTotal antimicrobial days of therapy   Rate of urine cultures sent
  Zimmerman,[32](#jgs15675-bib-0032){ref-type="ref"} 2014    NR                                                                                              Antibiotic prescribing rates                                                         NR

Abbreviations: EENTI, ear, eye, nose, and throat infection; NR, not reported; RTI, respiratory tract infection; UTI, urinary tract infection.

Antimicrobial Stewardship Interventions {#jgs15675-sec-0013}
---------------------------------------

Most of the studies were multifaceted (n = 15),[19](#jgs15675-bib-0019){ref-type="ref"}, [20](#jgs15675-bib-0020){ref-type="ref"}, [21](#jgs15675-bib-0021){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [35](#jgs15675-bib-0035){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} and the number of intervention strategies used per study varied from one to seven, with a median of four (Supplementary Table [S2](#jgs15675-supitem-0001){ref-type="supplementary-material"} provides a detailed list of strategies per study). The three most frequently used strategies were educational material (n = 13),[19](#jgs15675-bib-0019){ref-type="ref"}, [20](#jgs15675-bib-0020){ref-type="ref"}, [21](#jgs15675-bib-0021){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} educational meetings (n = 12),[19](#jgs15675-bib-0019){ref-type="ref"}, [20](#jgs15675-bib-0020){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} and guideline implementation (n = 7).[20](#jgs15675-bib-0020){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [35](#jgs15675-bib-0035){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} Six studies implemented an intervention to shift organizational culture[21](#jgs15675-bib-0021){ref-type="ref"}, [22](#jgs15675-bib-0022){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [27](#jgs15675-bib-0027){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"} (eg, creating a new onsite infectious disease consultation service or implementing an ASP). Other strategies that have been implemented in LTCFs included audit and feedback (n = 5),[20](#jgs15675-bib-0020){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [26](#jgs15675-bib-0026){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [35](#jgs15675-bib-0035){ref-type="ref"} reminders (n = 5),[25](#jgs15675-bib-0025){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} local opinion leader (n = 4),[28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}patient‐mediated interventions (n = 3),[23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"} continuous quality improvement (n = 2),[24](#jgs15675-bib-0024){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"} educational outreach (n = 2),[30](#jgs15675-bib-0030){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"} financial incentives (n = 2),[24](#jgs15675-bib-0024){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"} community of practice (n = 1),[33](#jgs15675-bib-0033){ref-type="ref"} and tailored interventions (n = 1).[31](#jgs15675-bib-0031){ref-type="ref"} More than half of the studies had an educational component (n = 14),[19](#jgs15675-bib-0019){ref-type="ref"}, [20](#jgs15675-bib-0020){ref-type="ref"}, [21](#jgs15675-bib-0021){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} and most studies had aspects beyond education (n = 13).[20](#jgs15675-bib-0020){ref-type="ref"}, [21](#jgs15675-bib-0021){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"}

Intervention Intensity and Resource {#jgs15675-sec-0014}
-----------------------------------

There was a vast variability in the level of intervention intensity and resources required. Intervention implementation ranged from a one‐time only session to 72 weekly commitments. Of 16 studies, 12 involved ongoing commitment (eg, use of a guideline or a tool), often in addition to the time allocated to participate in the intervention.[19](#jgs15675-bib-0019){ref-type="ref"}, [21](#jgs15675-bib-0021){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [27](#jgs15675-bib-0027){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [35](#jgs15675-bib-0035){ref-type="ref"} Interventions also tended to be outside of the routine practice of the daily workflow of the LTCF healthcare providers. Ten studies specified the profession of those delivering the intervention, which could involve pharmacists,[26](#jgs15675-bib-0026){ref-type="ref"}, [27](#jgs15675-bib-0027){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"} physicians,[22](#jgs15675-bib-0022){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [26](#jgs15675-bib-0026){ref-type="ref"}, [27](#jgs15675-bib-0027){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} and nurses,[19](#jgs15675-bib-0019){ref-type="ref"}, [22](#jgs15675-bib-0022){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} and often in multidisciplinary combinations.

Quality Appraisal {#jgs15675-sec-0015}
-----------------

Most of the studies had a high risk of bias,[19](#jgs15675-bib-0019){ref-type="ref"}, [21](#jgs15675-bib-0021){ref-type="ref"}, [22](#jgs15675-bib-0022){ref-type="ref"}, [23](#jgs15675-bib-0023){ref-type="ref"}, [24](#jgs15675-bib-0024){ref-type="ref"}, [25](#jgs15675-bib-0025){ref-type="ref"}, [26](#jgs15675-bib-0026){ref-type="ref"}, [27](#jgs15675-bib-0027){ref-type="ref"}, [28](#jgs15675-bib-0028){ref-type="ref"}, [29](#jgs15675-bib-0029){ref-type="ref"}, [30](#jgs15675-bib-0030){ref-type="ref"}, [31](#jgs15675-bib-0031){ref-type="ref"}, [32](#jgs15675-bib-0032){ref-type="ref"}, [33](#jgs15675-bib-0033){ref-type="ref"}, [34](#jgs15675-bib-0034){ref-type="ref"}, [35](#jgs15675-bib-0035){ref-type="ref"}, [36](#jgs15675-bib-0036){ref-type="ref"} with one moderate risk of bias[20](#jgs15675-bib-0020){ref-type="ref"} on methodological quality assessment; therefore, meta‐analysis did not exclude studies on the basis of the methodological quality, and sensitivity analysis was not conducted on the basis of methodological quality.

Meta‐Analysis {#jgs15675-sec-0016}
-------------

The meta‐analysis of the impact of antimicrobial stewardship strategies on overall antibiotic use in LTC included 11 studies that reported this outcome and demonstrated a statistically significant 14% reduction in antimicrobial use (95% CI = −8% to −20% \[ratio of means, 0.86, 95% CI = 0.80‐0.92\]; *P* \< .0001; see forest plot in Figure [2](#jgs15675-fig-0002){ref-type="fig"}). The subgroup analyses by study design showed that the reduction was similar regardless of study design (interaction *P* = .37) and remained statistically significant for cluster RCTs (10% reduction; 95% CI = −5% to −14%; *P* \< .001) and uncontrolled pre and post studies (18% reduction; 95% CI = −6% to −29%; *P* = .006); controlled pre and post studies followed the trend but did not reach statistical significance (15% reduction; 95% CI = −29% to 2%; *P* = .07). Collectively, the heterogeneity score was moderate (I^2^ = 69%), driven primarily by the subgroup of uncontrolled pre and post studies exhibiting high heterogeneity (I^2^ = 86%), whereas there was no heterogeneity among cluster RCTs (I^2^ = 0%) and controlled pre and post studies (I^2^ = 0%), indicating that the variation in the latter two subgroups is due to chance alone and not due to underlying differences. Two studies examined outcomes that were less comparable to the measures of overall antimicrobial use in the other studies; one examined total infections treated with antibiotics,[20](#jgs15675-bib-0020){ref-type="ref"} and the other assessed prescription counts for asymptomatic bacteriuria as a proportion of total urinary tract treatments.[19](#jgs15675-bib-0019){ref-type="ref"} Sensitivity analysis, excluding these two studies, yielded a nearly identical estimate to the main analysis (14% reduction; 95% CI = −7% to −21%; *P* = .0001). Visual inspection of the funnel plot (Figure [3](#jgs15675-fig-0003){ref-type="fig"}) suggested evidence of asymmetry with a lack of publication of smaller studies showing increased antibiotic use (ie, ratio of means, greater than one).

![Forest plot showing the impact of antimicrobial stewardship strategies on overall antibiotic use in long‐term care facilities, including the 11 studies that reported this outcome. Individual and pooled ratio of means with 95% confidence intervals (CIs) are shown, and pooled results were calculated using inverse variance weighting and random‐effects models. Pooled ratios of means are also presented separately for the subgroups of cluster randomized controlled trials (RCTs), controlled pre/post observational studies, and uncontrolled pre/post observational studies. ASP indicates antimicrobial stewardship program. \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com)\]](JGS-67-392-g002){#jgs15675-fig-0002}

![Funnel plot comparing the antimicrobial use effect measure, Ratio of means, for each of the 11 included studies (with different symbols for the cluster randomized controlled trial \[RCT\] \[circles\] and controlled \[diamonds\] and uncontrolled \[squares\] pre/post study subgroups) on the x‐axis, with each study\'s effect measure precision, expressed as the SE of the natural logarithm of the ratio of means, SE(log\[Ratio of Means\]), on the y‐axis demonstrating asymmetry with a lack of publication of smaller (lower precision) studies showing increased antibiotic use (ie, ratio of means, greater than one).](JGS-67-392-g003){#jgs15675-fig-0003}

Discussion {#jgs15675-sec-0017}
==========

The emerging public health threat of AMR requires a collective effort to improve antimicrobial use across the healthcare continuum. The US Centers for Medicare and Medicaid Services has mandated that ASP is required in LTCFs since 2017.[8](#jgs15675-bib-0008){ref-type="ref"} The growing interest in implementation of antimicrobial stewardship in LTCFs is seen in the number of studies published in recent years. However, there are only a handful of qualitative reviews available, most likely because of the limited primary research conducted. Further to narratively describing ASP in LTCFs, some have also categorized interventions as centralized (programmatic) vs decentralized (nonprogrammatic)[9](#jgs15675-bib-0009){ref-type="ref"} or by a human factor engineering approach including five work system components that interact and influence one another (eg, specific task, tools, and technology).[37](#jgs15675-bib-0037){ref-type="ref"}

This systematic review is the first to provide quantitative analysis of the impact of antimicrobial stewardship interventions in LTCFs and suggests that antimicrobial stewardship interventions contribute to a significant reduction in antimicrobial use by 14% when pooling across all types of interventions. It was reasonable to expect heterogeneity because of pooling of different interventions and study designs; however, the direction of the effect consistently favored the intervention, and the result was robust across subtypes of studies and sensitivity analysis. Only one study reported multiple time points for outcome measurements,[25](#jgs15675-bib-0025){ref-type="ref"} and the furthest time point was included for meta‐analysis. It is noteworthy that reductions in antimicrobial use were similar for both time points, suggesting that the decrease was sustained over 2.5 years in this single‐center study. Sensitivity analysis (described in the Figure [2](#jgs15675-fig-0002){ref-type="fig"} legend) also showed that the overall effect remained unchanged.

This review also used an implementation approach to describe antimicrobial stewardship interventions in LTCFs using the EPOC taxonomy of health system interventions with additional information on intervention intensity and resource requirements. This framework offers a new approach to understand the current landscape while recognizing that tailored interventions may be required by different LTCFs, depending on various factors (eg, available resources or specific concerns needed to be addressed). Programs described by the included studies are all unique, with no standardization of strategies, evaluation, or reporting. Intervention intensity varied and often required time commitment outside of daily routines. Expertise in antimicrobial stewardship is often necessary because pharmacists and physician specialists are frequently involved in intervention delivery or providing ongoing assistance. Most studied interventions are multifaceted, with different strategies implemented simultaneously; consequently, the benefits of specific strategies are unclear. Multifaceted interventions are not necessarily more effective than single‐component interventions,[38](#jgs15675-bib-0038){ref-type="ref"} especially in a resource‐limited setting. Nevertheless, it is reasonable to allow flexibility in designing antimicrobial stewardship strategies to be implemented in LTCFs to adequately reflect local needs.

Interventions with an enabling component (eg, audit and feedback) consistently increase the effect of interventions in hospital settings, and interventions that include audit and feedback have been shown to be more effective than those that did not.[39](#jgs15675-bib-0039){ref-type="ref"} However, LTCFs are unlikely to be able to implement intense and resource‐heavy interventions, such as the audit and feedback strategies used in hospital settings.[9](#jgs15675-bib-0009){ref-type="ref"} Thus, it is not surprising to see a wide range of antimicrobial stewardship strategies applied in LTCFs. Although knowledge gaps may influence antibiotic prescribing and decision making, education alone is insufficient to generate sustainable improvement in antibiotic prescribing and passive education activities should be combined with other antimicrobial stewardship strategies.[9](#jgs15675-bib-0009){ref-type="ref"}, [40](#jgs15675-bib-0040){ref-type="ref"} It is, therefore, encouraging to see that 12 of the 13 included studies with an education component included aspects beyond education. Furthermore, three of those studies also included a patient education component, which may be an essential objective because pressure from patients and family may contribute to prescribing decisions in LTCFs.[9](#jgs15675-bib-0009){ref-type="ref"}, [41](#jgs15675-bib-0041){ref-type="ref"}

The main challenges of conducting meta‐analysis on the impact of antimicrobial stewardship strategies in LTCFs are the few published studies and the lack of diversity of study designs, interventions, and outcomes. A review found that less than 0.3% of published citations on antibiotic use and resistance focused on LTCFs, indicating a lack of research and development in this area compared with other healthcare settings (eg, primary care).[1](#jgs15675-bib-0001){ref-type="ref"} Moreover, the review found publications were mostly focused on antimicrobial resistance, resulting in relatively few studies reporting antibiotic use.[1](#jgs15675-bib-0001){ref-type="ref"} A second limitation of this systematic review is the lack of an appropriate and validated quality appraisal tool for this topic area. The use of the EPHPP quality appraisal tool, which provides assessment based on six individual quality domains, judged most of the studies to be at high risk of bias. The decrease in antibiotic use determined by the pooled analysis may be an overestimate because of potential publication bias as all studies demonstrated effectiveness (ie, decreased antibiotic use), although not all were statistically significant. This may not be surprising because it is less likely for groups to publish ASP implementation studies in which antibiotic use increased. Last, no studies reported cost‐related outcomes. Given the limited resources available in this setting, sustainability and cost are vital factors to consider and should be addressed.

Conclusion {#jgs15675-sec-0018}
==========

This systematic review provides the current landscape of antimicrobial stewardship strategies implemented in LTCFs and resource‐related factors to consider when designing an ASP in this setting. Antimicrobial stewardship strategies in LTCFs differ considerably in design and resource intensity. Given the variability in interventions used and the presence of multifaceted approaches, there is no one specific strategy that can be recommended at this time to improve antibiotic use in residents of LTCFs. It is also important for ASP researchers to remain cautious about potential publication bias. However, collectively, antimicrobial stewardship strategies appear to be associated with significantly reduced antimicrobial use in this challenging setting.
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